Ownership history in MWG Management Ltd. · 20 quarters on record
This page tracks every 13F SEC filing in which MWG Management Ltd. reported a position in Beam Therapeutics Inc. (BEAM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2,266,934 | — | 0% | 67.66% | $55.0M | $24.27 |
| 2025 Q2 | UNCHANGED | 2,266,934 | — | 0% | 74.30% | $38.6M | $17.01 |
| 2025 Q1 | UNCHANGED | 2,266,934 | — | 0% | 75.44% | $44.27B | $19.53 |
| 2024 Q4 | UNCHANGED | 2,266,934 | — | 0% | 75.61% | $56.22B | $24.80 |
| 2024 Q3 | UNCHANGED | 2,266,934 | — | 0% | 61.51% | $55.54B | $24.50 |
| 2024 Q2 | REDUCED | 2,266,934 | -80,000 | -3.4% | 58.01% | $53.1M | $23.43 |
| 2024 Q1 | UNCHANGED | 2,346,934 | — | 0% | 57.42% | $77.5M | $33.04 |
| 2023 Q4 | UNCHANGED | 2,346,934 | — | 0% | 53.74% | $63.9M | $27.22 |
| 2023 Q3 | UNCHANGED | 2,346,934 | — | 0% | 54.70% | $56.4M | $24.05 |
| 2023 Q2 | UNCHANGED | 2,346,934 | — | 0% | 45.33% | $74.9M | $31.93 |
As of 2025 Q4 — sorted by position size